119 related articles for article (PubMed ID: 12711862)
1. Oxidized LDL autoantibodies are related to apolipoprotein E phenotype, independently of postprandial change in plasma triglycerides and LDL size, among patients with angiographically verified coronary artery disease and healthy controls.
Metso S; Nikkilä M; Laippala P; Jaakkola O; Solakivi T; Lehtimäki T
J Biomed Sci; 2003; 10(3):345-51. PubMed ID: 12711862
[TBL] [Abstract][Full Text] [Related]
2. Postprandial plasma lipoprotein changes in relation to apolipoprotein E phenotypes and low density lipoprotein size in men with and without coronary artery disease.
Nikkilä M; Solakivi T; Lehtimäki T; Koivula T; Laippala P; Aström B
Atherosclerosis; 1994 Apr; 106(2):149-57. PubMed ID: 8060376
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women.
Lehtinen S; Lehtimäki T; Sisto T; Salenius JP; Nikkilä M; Jokela H; Koivula T; Ebeling F; Ehnholm C
Atherosclerosis; 1995 Apr; 114(1):83-91. PubMed ID: 7605379
[TBL] [Abstract][Full Text] [Related]
4. Independent effects of Apo E phenotype and plasma triglyceride on lipoprotein particle sizes in the fasting and postprandial states.
Dart AM; Cooper B
Arterioscler Thromb Vasc Biol; 1999 Oct; 19(10):2465-73. PubMed ID: 10521377
[TBL] [Abstract][Full Text] [Related]
5. Impact of postprandial lipaemia on low-density lipoprotein (LDL) size and oxidized LDL in patients with coronary artery disease.
Granér M; Kahri J; Nakano T; Sarna SJ; Nieminen MS; Syvänne M; Taskinen MR
Eur J Clin Invest; 2006 Nov; 36(11):764-70. PubMed ID: 17032343
[TBL] [Abstract][Full Text] [Related]
6. Accumulation of apoE-enriched triglyceride-rich lipoproteins in patients with coronary artery disease.
Barbagallo CM; Rizzo M; Noto D; Frasheri A; Pernice V; Rubino A; Pieri D; Pinto V; Cefalù AB; Giordano C; Notarbartolo A; Averna MR
Metabolism; 2006 May; 55(5):662-8. PubMed ID: 16631444
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E phenotypes, serum lipoproteins and apolipoproteins in angiographically assessed coronary heart disease.
Stuyt PM; Brenninkmeijer BJ; Demacker PN; Hendriks JC; van Elteren P; Stalenhoef AF; van 't Laar A
Scand J Clin Lab Invest; 1991 Sep; 51(5):425-35. PubMed ID: 1947727
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to oxidized low-density lipoproteins and angiographically assessed coronary artery disease in white patients.
Rossi GP; Cesari M; De Toni R; Zanchetta M; Maiolino G; Pedon L; Ganzaroli C; Maiolino P; Pessina AC
Circulation; 2003 Nov; 108(20):2467-72. PubMed ID: 14581399
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease.
Lehtimäki T; Lehtinen S; Solakivi T; Nikkilä M; Jaakkola O; Jokela H; Ylä-Herttuala S; Luoma JS; Koivula T; Nikkari T
Arterioscler Thromb Vasc Biol; 1999 Jan; 19(1):23-7. PubMed ID: 9888862
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E phenotypes and serum lipids in newborns and 3-year-old children: the Cardiovascular Risk in Young Finns Study.
Lehtimäki T; Porkka K; Viikari J; Ehnholm C; Akerblom HK; Nikkari T
Pediatrics; 1994 Oct; 94(4 Pt 1):489-93. PubMed ID: 7936857
[TBL] [Abstract][Full Text] [Related]
11. Changes of autoantibodies against oxidatively modified low density lipoproteins during long-term LDL-apheresis.
Turk Z; Mrzljak V; Turk N; Metelko Z
Diabetes Nutr Metab; 1999 Dec; 12(6):413-7. PubMed ID: 10782563
[TBL] [Abstract][Full Text] [Related]
12. Women have a larger and less atherogenic low density lipoprotein particle size than men.
Nikkilä M; Pitkäjärvi T; Koivula T; Solakivi T; Lehtimäki T; Laippala P; Jokela H; Lehtomäki E; Seppä K; Sillanaukee P
Atherosclerosis; 1996 Jan; 119(2):181-90. PubMed ID: 8808495
[TBL] [Abstract][Full Text] [Related]
13. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
[TBL] [Abstract][Full Text] [Related]
14. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
[TBL] [Abstract][Full Text] [Related]
15. The effect of apolipoprotein E isoform difference on postprandial lipoprotein in patients matched for triglycerides, LDL-cholesterol, and HDL-cholesterol.
Superko HR; Haskell WL
Artery; 1991; 18(6):315-25. PubMed ID: 1750804
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E phenotypes and plasma lipids in diabetic children and adolescents.
Salo MK; Rantanen R; Huupponen T; Lehtimäki T; Jokela H
Eur J Pediatr; 1993 Jul; 152(7):564-8. PubMed ID: 8354314
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E phenotypes in Finnish youths: a cross-sectional and 6-year follow-up study.
Lehtimäki T; Moilanen T; Viikari J; Akerblom HK; Ehnholm C; Rönnemaa T; Marniemi J; Dahlen G; Nikkari T
J Lipid Res; 1990 Mar; 31(3):487-95. PubMed ID: 2341810
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein-E phenotype and basal activity of low-density lipoprotein receptor are independent of changes in plasma lipoprotein subfractions after cholesterol ingestion in Japanese subjects.
Homma Y; Kobayashi T; Yamaguchi H; Ozawa H; Homma K; Ishiwata K
Nutrition; 2001 Apr; 17(4):310-4. PubMed ID: 11369170
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies to malondialdehyde-modified low-density lipoprotein in patients with angiographically confirmed coronary artery disease.
McDowell A; Young IS; Wisdom GB
J Pharm Pharmacol; 2002 Dec; 54(12):1651-7. PubMed ID: 12542895
[TBL] [Abstract][Full Text] [Related]
20. Soluble LDL-immune complexes in type 2 diabetes and vascular disease.
Turk Z; Sesto M; Skodlar J; Ferencak G; Turk N; Stavljenić-Rukavina A
Horm Metab Res; 2002 Apr; 34(4):196-201. PubMed ID: 11987029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
